Lactobacillus pentosus strain b240 suppresses pneumonia induced by Streptococcus pneumoniae in mice

Letters in Applied Microbiology

Volumn 53, Issue 1, 2011, Pages 35-43

  Tanaka, A ^a   Seki, M ^a   Yamahira, S ^b   Noguchi, H ^b   Kosai, K ^a   Toba, M ^b   Morinaga, Y ^a   Miyazaki, T ^a   Izumikawa, K ^a   Kakeya, H ^a   Yamamoto, Y ^a   Yanagihara, K ^a   Tashiro, T ^a   Kohda, N ^b   Kohno, S ^a  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Cytokines; Lactobacillus pentosus strain b240; Probiotics; Streptococcus pneumoniae; Toll like receptors

Indexed keywords

ENZYME ACTIVITY; HISTOLOGY; MAMMALS;

CYTOKINES; INFECTIOUS DISEASE; INFLAMMATORY RESPONSE; INHIBITORY EFFECT; LACTOBACILLUS PENTOSU STRAIN B240; ORAL ADMINISTRATION; ORAL INTAKE; PROBIOTICS; STREPTOCOCCUS PNEUMONIAE; TOLL-LIKE RECEPTORS;

TISSUE;

ANTIBIOTIC AGENT; B 240; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 2; SODIUM CHLORIDE; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

BACTERIUM; EXPERIMENTAL STUDY; GENE EXPRESSION; IMMUNE RESPONSE; INFECTIOUS DISEASE; INHIBITOR; PROBIOTICS; RODENT; SURVIVAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE STORM; DISEASE SEVERITY; LACTOBACILLUS; LACTOBACILLUS PENTOSUS; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; SURVIVAL TIME; TREATMENT DURATION; WEIGHT REDUCTION;

ANIMALIA; LACTOBACILLUS PENTOSUS; MURINAE; MUS; STREPTOCOCCUS PNEUMONIAE;

EID: 79958773204     PISSN: 02668254     EISSN: 1472765X     Source Type: Journal    
DOI: 10.1111/j.1472-765X.2011.03079.x     Document Type: Article

References (39)

1. Akira, S. (2006) TLR signaling. Curr Top Microbiol Immunol 311, 1-16.
2. Anon (2006) The Japanese Respiratory Society guidelines for the management of community-acquired pneumonia in adults. Respirology 11, S1-S133.
3. Anon (2009) The Japanese Respiratory Society guidelines for the management of hospital-acquired pneumonia in adults 2008. Respirology 14, S1-S71.
4. Blum, S., Alvarez, S., Haller, D., Perez, P. and Schiffrin, E.J. (1999) Intestinal microflora and the interaction with immunocompetent cells. Antonie Van Leeuwenhoek 76, 199-205.
5. Bringel, F., Castioni, A., Olukoya, D.K., Felis, G.E., Torriani, S. and Dellaglio, F. (2005) Lactobacillus plantarum subsp. argentoratensis subsp. nov., isolated from vegetable matrices. Int J Syst Evol Microbiol 55, 1629-1634.
6. Cammarota, M., De Rosa, M., Stellavato, A., Lamberti, M., Marzaioli, I. and Giuliano, M. (2009) In vitro evaluation of Lactobacillus plantarum DSMZ 12028 as a probiotic: emphasis on innate immunity. Int J Food Microbiol 135, 90-98.
7. Fisman, DN, Abrutyn, E, Spaude, KA, Kim, A, Kirchner, C and Daley, J. (2006) Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clin Infect Dis 42, 1093-1101.
8. Fukuyama, Y., King, J.D., Kataoka, K., Kobayashi, R., Gilbert, R.S., Oishi, K., Hollingshead, S.K., Briles, D.E. et al. (2010) Secretory-IgA antibodies play an important role in the immunity to Streptococcus pneumoniae. J Immunol 185, 1755-1762.
9. Fuller, R. (1991) Probiotics in human medicine. Gut 32, 439-442.
10. Gill, H.S. and Guarner, F. (2004) Probiotics and human health: a clinical perspective. Postgrad Med J 80, 516-526.
11. Gill, H.S., Rutherfurd, K.J., Prasad, J. and Gopal, P.K. (2000) Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br J Nutr 83, 167-176.
12. Harata, G., He, F., Hiruta, N., Kawase, M., Kubota, A., Hiramatsu, M. and Yausi, H. (2010) Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses. Lett Appl Microbiol 50, 597-602.
13. Ishikawa, H., Kutsukake, E., Fukui, T., Sato, I., Shirai, T., Kurihara, T., Okada, N., Danbara, H. et al. (2010) Oral administration of heat-killed Lactobacillus plantarum strain b240 protected mice against Salmonella enterica Serovar Typhimurium. Biosci Biotechnol Biochem 74, 1338-1342.
14. Kawase, M., He, F., Kubota, A., Harata, G. and Hiramatsu, M. (2010) Oral administration of lactobacilli from human intestinal tract protects mice against influenza virus infection. Lett Appl Microbiol 51, 6-10.
15. Kenzel, S, Mancuso, G, Malley, R, Teti, G, Golenbock, DT and Henneke, P. (2006) c-Jun kinase is a critical signaling molecule in a neonatal model of group B streptococcal sepsis. J Immunol 176, 3181-8.
16. Kishi, K., Kotani, Y., Yamahira, S., Toba, M., Okamatsu, H., Mihara, S., Tsuruta, Y., Takehara, M. et al. (2006) Lactobacillus plantarum ONRIC b0240 enhanced salivary IgA in healthy adult volunteers. Jpn J Lactic Acid Bact 17, 132-137.
17. Kobayashi, N., Saito, T., Uematsu, T., Kishi, K., Toba, M., Kohda, N. and Suzuki, T. (2011) Oral administration of heat-killed Lactobacillus pentosus strain b240 augments protection against influenza virus infection in mice. Int Immunopharmacol 11, 199-203.
18. Kosai, K., Seki, M., Yanagihara, K., Nakamura, S., Kurihara, S., Izumikawa, K., Kakeya, H., Yamamoto, Y. et al. (2008) Elevated levels of high mobility group box chromosomal protein-1 (HMGB-1) in sera from patients with severe bacterial pneumonia coinfected with influenza virus. Scand J Infect Dis 40, 338-342.
19. Kotani, Y., Shinkai, S., Okamatsu, H., Toba, M., Ogawa, K., Yoshida, H., Fukaya, T., Fujiwara, Y. et al. (2010) Oral intake of Lactobacillus pentosus strain b240 accelerates salivary immunoglobulin A secretion in the elderly: a randomized, placebo-controlled, double-blind trial. Immun Ageing 7, 11.
20. Lee, C.J., Lee, L.H. and Gu, X.X. (2005) Mucosal immunity induced by pneumococcal glycoconjugate. Crit Rev Microbiol 31, 137-144.
21. Mandell, L.A., Wunderink, R.G., Anzueto, A., Bartlett, J.G., Campbell, G.D., Dean, N.C., Dowell, S.F., File, T.M.. Jr et al. (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44, S27-72.
22. Ménard, S., Candalh, C., Bambou, J.C., Terpend, K., Cerf-Bensussan, N. and Heyman, M. (2004) Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut 53, 821-828.
23. Miyauchi, E., Morita, H., Okuda, J., Sashihara, T., Shimizu, M. and Tanabe, S. (2008) Cell wall fraction of Enterococcus hirae ameliorates TNF-alpha-induced barrier impairment in the human epithelial tight junction. Lett Appl Microbiol 46, 469-476.
24. Okada, S., Daengsubha, W., Uchimura, T., Ohara, N. and Kozaki, M. (1986) Flora of lactic acid bacteria in Miang produced in northern thailand. J Gen Appl Microbiol 32, 57-65.
25. Racedo, S., Villena, J., Medina, M., Agüero, G., Rodríguez, V. and Alvarez, S. (2006) Lactobacillus casei administration reduces lung injuries in a Streptococcus pneumoniae infection in mice. Microbes Infect 8, 2359-2366.
26. Saito, A., Kohno, S., Matsushima, T., Watanabe, A., Oizumi, K., Yamaguchi, K. and Oda, H. (2006) Prospective multicenter study of the causative organisms of community-acquired pneumonia in adults in Japan. J Infect Chemother 12, 63-69.
27. Seki, M., Yanagihara, K., Higashiyama, Y., Fukuda, Y., Kaneko, Y., Ohno, H., Miyazaki, Y., Hirakata, Y. et al. (2004a) Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice. Eur Respir J 24, 143-149.
28. Seki, M., Higashiyama, Y., Tomono, K., Yanagihara, K., Ohno, H., Kaneko, Y., Izumikawa, K., Miyazaki, Y. et al. (2004b) Acute infection with influenza virus enhances susceptibility to fatal pneumonia following Streptococcus pneumoniae infection in mice with chronic pulmonary colonization with Pseudomonas aeruginosa. Clin Exp Immunol 137, 35-40.
29. Seki, M., Watanabe, A., Mikasa, K., Kadota, J. and Kohno, S. (2008) Revision of the severity rating and classification of hospital-acquired pneumonia in the Japanese Respiratory Society guidelines. Respirology 13, 880-885.
30. Seki, M., Kohno, S., Newstead, M.W., Zeng, X., Bhan, U., Lukacs, N.W., Kunkel, S.L. and Standiford, T.J. (2010) Critical role of IL-1 receptor-associated kinase-M in regulating chemokine-dependent deleterious inflammation in murine influenza pneumonia. J Immunol 184, 1410-1418.
31. Strieter, R.M., Belperio, J.A. and Keane, M.P. (2002) Cytokines in innate host defense in the lung. J Clin Invest 109, 699-705.
32. Takashima, K., Tateda, K., Matsumoto, T., Iizawa, Y., Nakao, M. and Yamaguchi, K. (1997) Role of tumour necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice. Infect Immun 65, 257-260.
33. Tamura, S., Funato, H., Hirabayashi, Y., Kikuta, K., Suzuki, Y., Nagamine, T., Aizawa, C., Nakagawa, M. et al. (1990) Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza. Vaccine 8, 479-485.
34. Turchet, P., Laurenzano, M., Auboiron, S. and Antoine, J.M. (2003) Effect of fermented milk containing the probiotic Lactobacillus casei DN-114001 on winter infections in free-living elderly subjects: a randomized, controlled pilot study. J Nutr Health Aging 7, 75-77.
35. Villena, J., Medina, M., Raya, R. and Alvarez, S. (2008) Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection. Can J Microbiol 54, 845-853.
36. World Health Organization (2000) Nutrition for Health and Development, pp. 9-10. Geneva: WHO.
37. Xu, F, Droemann, D, Rupp, J, Shen, H, Wu, X, Goldmann, T, Hippenstiel, S, Zabel, P et al. (2008) Modulation of the inflammatory response to Streptococcus pneumoniae in a model of acute lung tissue infection. Am J Respir Cell Mol Biol 39, 522-9.
38. Yamahira, S., Toba, M., Kishi, K. and Okamatsu, Y. (2006) Stimulation of mucosal immune system by lactic acid bacteria originating in tea. Jpn J Lactic Acid Bact 17, 57-60.
39. Yanagihara, K., Fukuda, Y., Seki, M., Izumikawa, K., Miyazaki, Y., Hirakata, Y., Tsukamoto, K., Yamada, Y. et al. (2007) Effects of specific neutrophil elastase inhibitor, sivelestat sodium hydrate, in murine model of severe pneumococcal pneumonia. Exp Lung Res 33, 71-80.